BGM-2121
BGM-2121-001
Phase 1 small_molecule active
Quick answer
BGM-2121 for Advanced Solid Tumors is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active